Brookfield Renewable Powerr Fund Stock News

The headline numbers for Brookfield Renewable (BEP) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Stre

Fitch Ratings downgraded the US Federal Government from AAA to AA+, causing the stock market to roil. Real estate investment trusts (REITs) have fared better than tech stocks in the day after the down

Brookfield Renewable expects to acquire Westinghouse Electric in partnership with Cameco this year. The acquirers, however, are reportedly being probed.

Energy is a fundamental pillar in our survival, but it's getting more expensive to tap into this resource. Gas prices continue to rise, and current geopolitical disputes are only making it worse.

AbbVie is a Dividend King that is navigating some headwinds better than expected. Brookfield Renewable stands to profit with a brighter spotlight on carbon emissions reduction.

Enterprise Products Partners has a historically high yield and more than enough cash to cover its distribution. Brookfield Renewable's dividends should keep growing.

When investors think of energy stocks, they often overlook solar stocks. That seems to be the case even if solar stocks are ready to explode!

Blackstone sees $1 trillion of investment opportunities in digital infrastructure over the next five years. Energy transition will require $4.5 trillion of investment annually for the next couple of d

Discerning investors are locking their radars onto the top renewable energy stocks in navigating the rapidly transforming energy landscape. These stocks aren't just bright spots on the horizon; they

AbbVie is a Dividend King with a long history of innovation. Brookfield Renewable has a clear path to long-term growth.

Renewable energy could produce a third of the world's power by the end of this decade. Brookfield Renewable and NextEra Energy are leaders in developing renewable energy projects.

Dividend King Black Hills is a small, boring utility that operates in markets benefiting from in-migration. Brookfield Renewable has an excellent dividend growth track record.

Brookfield Renewable expects to deliver average annual total returns of between 12% and 15%. The low end of that range would more than triple an initial investment in 10 years.

Axsome Therapeutics' current drugs and pipeline programs look especially promising. Brookfield Renewable could double in six years if it hits the low end of its projected growth range.

The tailwinds behind energy stocks are greater than the purported headwinds because the demand for oil and gas is so large. The global under-investment in fossil fuel production over the past 10-plus